Nvidia (NVDA) plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co. (LLY), aiming to speed up the use of artificial intelligence in the pharmaceutical industry. Jessica Nix has more on "Bloomberg Open Interest."

Bloomberg videos, provided by MT Newswires